BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 29470609)

  • 1. [New aspects in systemic treatment of atopic dermatitis].
    Werfel T; Wollenberg A; Pumnea T; Heratizadeh A
    Hautarzt; 2018 Mar; 69(3):217-224. PubMed ID: 29470609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel systemic drugs in treatment of atopic dermatitis: results from phase II and phase III studies published in 2017/2018.
    Werfel T
    Curr Opin Allergy Clin Immunol; 2018 Oct; 18(5):432-437. PubMed ID: 30095475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-13 antagonists in the treatment of atopic dermatitis.
    Tubau C; Puig L
    Immunotherapy; 2021 Mar; 13(4):327-344. PubMed ID: 33430628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current and upcoming treatments of adult atopic dermatitis].
    Lacour JP
    Ann Dermatol Venereol; 2017 Dec; 144 Suppl 5():VS29-VS37. PubMed ID: 29433635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What's New in Atopic Dermatitis.
    Renert-Yuval Y; Guttman-Yassky E
    Dermatol Clin; 2019 Apr; 37(2):205-213. PubMed ID: 30850043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel therapies in the treatment of atopic dermatitis.
    Zhong CS; Elmariah SB
    Semin Cutan Med Surg; 2018 Sep; 37(3):190-197. PubMed ID: 30215637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic therapy of atopic dermatitis in children and adults.
    Simon D
    Curr Probl Dermatol; 2011; 41():156-164. PubMed ID: 21576956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-IL-4 receptor alpha antibody dupilumab: facing a new era in treating atopic dermatitis.
    Tsianakas A; Luger TA
    Expert Opin Biol Ther; 2015; 15(11):1657-60. PubMed ID: 26457448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Status quo and prospects for systemic therapy of atopic dermatitis. Biologics ante portas].
    Biedermann T; Werfel T
    Hautarzt; 2015 Feb; 66(2):108-13. PubMed ID: 25645542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dupilumab: A review of its use in the treatment of atopic dermatitis.
    Gooderham MJ; Hong HC; Eshtiaghi P; Papp KA
    J Am Acad Dermatol; 2018 Mar; 78(3 Suppl 1):S28-S36. PubMed ID: 29471919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-31 and interleukin-31 receptor: New therapeutic targets for atopic dermatitis.
    Nakashima C; Otsuka A; Kabashima K
    Exp Dermatol; 2018 Apr; 27(4):327-331. PubMed ID: 29524262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic Treatment for Severe Atopic Dermatitis.
    Giavina-Bianchi M; Giavina-Bianchi P
    Arch Immunol Ther Exp (Warsz); 2019 Apr; 67(2):69-78. PubMed ID: 30159581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatments for Childhood Atopic Dermatitis: an Update on Emerging Therapies.
    Chu CY
    Clin Rev Allergy Immunol; 2021 Oct; 61(2):114-127. PubMed ID: 32607924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies.
    Davis DMR; Drucker AM; Alikhan A; Bercovitch L; Cohen DE; Darr JM; Eichenfield LF; Frazer-Green L; Paller AS; Schwarzenberger K; Silverberg JI; Singh AM; Wu PA; Sidbury R
    J Am Acad Dermatol; 2024 Feb; 90(2):e43-e56. PubMed ID: 37943240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Old and New Systemic Treatments for Moderate to Severe Atopic Dermatitis.
    Yim HJ; Jean T; Ong PY
    Curr Allergy Asthma Rep; 2024 May; 24(5):289-301. PubMed ID: 38632138
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologics for Atopic Dermatitis.
    Boguniewicz M
    Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dupilumab use in atopic dermatitis and beyond in skin diseases.
    Fourzali K; Golpanian RS; Yosipovitch G
    Immunotherapy; 2020 Dec; 12(17):1221-1235. PubMed ID: 32892674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dupilumab in the treatment of moderate-to-severe atopic dermatitis.
    Kraft M; Worm M
    Expert Rev Clin Immunol; 2017 Apr; 13(4):301-310. PubMed ID: 28165826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the immune landscape in atopic dermatitis: The era of biologics and emerging therapeutic approaches.
    Moyle M; Cevikbas F; Harden JL; Guttman-Yassky E
    Exp Dermatol; 2019 Jul; 28(7):756-768. PubMed ID: 30825336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibodies for the treatment of atopic dermatitis.
    Renert-Yuval Y; Guttman-Yassky E
    Curr Opin Allergy Clin Immunol; 2018 Aug; 18(4):356-364. PubMed ID: 29870461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.